KRISTIN MULLALLY: Open Payments
NPI 1508014028 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,218 in 205 payments from 25 companies in 2025. Trend: 2023 $1,755 · 2024 $2,451 · 2025 $3,218
Food & beverage: $3,218
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 40 | $498 |
| ABBVIE INC. | 26 | $338 |
| Novo Nordisk Inc | 20 | $324 |
| AstraZeneca Pharmaceuticals LP | 7 | $324 |
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $319 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $278 |
| Amgen Inc. | 26 | $255 |
| Lilly USA, LLC | 9 | $114 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| Axsome Therapeutics, Inc. | 5 | $91 |
Products named: Kerendia, AIRSUPRA, CAPLYTA, NURTEC ODT, OTEZLA, VRAYLAR, Wegovy, REXULTI.
Industry payments across NY — which companies pay providers there.
